Innovation

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
January 9, 2023

Nashville Biosciences and Illumina announce sequencing agreement with Amgen

Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.

By VUMC News and Communications
November 3, 2022

‘DNA’ Podcast Hosts Two Climate and Health Twitter Spaces Chats

Climate and Health conversations will take place on Nov. 13 and 14, from 12:15 pm – 1 pm CT on Twitter Spaces.

By Holly Fletcher
Kristy Sinkfield, MEd, left, hosted a panel discussion with Mamie Williams, MPH, MSN, FNP-BC, Mary Duvanich, MSN, MMHC, Novonda Lilly, and Marques Bradshaw, MD, during Strategy Share 2022. The discussion was on promoting diversity, equity and inclusion throughout VUMC. (photo by Erin O. Smith)
November 1, 2022

Strategy Share 2022 spotlights VUMC’s successes in making health care personal

Strategy Share 2022 was centered on initiatives and programs that advance the three components of the Medical Center’s Strategic Directions: Making Diversity and Inclusion Intentional, Design for Patients and Families, and Discover, Learn and Share.

By Jill Clendening
September 22, 2022

VUMC to lead AI ethics core for NIH project

Vanderbilt researchers will lead and comprise the greater part of an artificial intelligence research ethics core for a National Institutes of Health (NIH) program called Bridge to Artificial Intelligence, or Bridge2AI.

By Paul Govern
September 8, 2022

Study tests drug to illuminate cancer during surgery

A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.

By Craig Boerner
September 5, 2022

Panoramic ‘DNA’ podcast Season 3 explores elements of well-being

By Holly Fletcher
August 24, 2022

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.
By Bill Snyder
August 8, 2022

Say hello. ‘DNA’ podcast series coming Fall 2022

Be one of the first to preview the all-new ‘Vanderbilt Health DNA: Discoveries in Action’ podcast series. #ListenDNA.
By Holly Fletcher
July 15, 2022

‘DNA’ podcast goes live: July 20 Twitter Spaces chat about mental health, teens

Season 3 of the “Vanderbilt Health DNA: Discoveries in Action” podcast series will kick off with a live Twitter Spaces chat about mental health, featuring several teens from the Boys & Girls Clubs of Middle Tennessee.
By Holly Fletcher
May 31, 2022

$10 million gift from Brock family to establish Brock Family Center for Applied Innovation

By Nancy Humphrey
May 19, 2022

Steaban receives Outstanding Operational Partner Award

Steaban, MSN, RN, NEA-BC, received the Outstanding Operational Partner Award during the Vanderbilt Symposium on Implementation Research in the Learning Health System.
By VUMC News and Communications
April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.
By Bill Snyder
February 17, 2022

Pandemic leads to broader use of monoclonal antibodies

Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.
By Bill Snyder
1 2 3 4 5 6 7